21-46117958-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001849.4(COL6A2):​c.1116+22C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00253 in 1,602,654 control chromosomes in the GnomAD database, including 71 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.012 ( 40 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 31 hom. )

Consequence

COL6A2
NM_001849.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0870

Publications

2 publications found
Variant links:
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
COL6A2 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1B
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
  • Bethlem myopathy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myosclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 21-46117958-C-T is Benign according to our data. Variant chr21-46117958-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 93899.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0123 (1870/152142) while in subpopulation AFR AF = 0.0407 (1689/41524). AF 95% confidence interval is 0.0391. There are 40 homozygotes in GnomAd4. There are 877 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 40 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A2NM_001849.4 linkc.1116+22C>T intron_variant Intron 12 of 27 ENST00000300527.9 NP_001840.3 P12110-1A0A384MDP3
COL6A2NM_058174.3 linkc.1116+22C>T intron_variant Intron 12 of 27 NP_478054.2 P12110-2
COL6A2NM_058175.3 linkc.1116+22C>T intron_variant Intron 12 of 27 NP_478055.2 P12110-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A2ENST00000300527.9 linkc.1116+22C>T intron_variant Intron 12 of 27 1 NM_001849.4 ENSP00000300527.4 P12110-1
COL6A2ENST00000397763.6 linkc.1116+22C>T intron_variant Intron 12 of 27 5 ENSP00000380870.1 P12110-2
COL6A2ENST00000409416.6 linkc.1116+22C>T intron_variant Intron 11 of 26 5 ENSP00000387115.1 P12110-3

Frequencies

GnomAD3 genomes
AF:
0.0123
AC:
1868
AN:
152024
Hom.:
40
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0407
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00831
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00962
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.00341
AC:
818
AN:
239790
AF XY:
0.00251
show subpopulations
Gnomad AFR exome
AF:
0.0395
Gnomad AMR exome
AF:
0.00422
Gnomad ASJ exome
AF:
0.000105
Gnomad EAS exome
AF:
0.0000558
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000471
Gnomad OTH exome
AF:
0.00242
GnomAD4 exome
AF:
0.00151
AC:
2186
AN:
1450512
Hom.:
31
Cov.:
32
AF XY:
0.00131
AC XY:
942
AN XY:
719852
show subpopulations
African (AFR)
AF:
0.0400
AC:
1334
AN:
33310
American (AMR)
AF:
0.00496
AC:
219
AN:
44124
Ashkenazi Jewish (ASJ)
AF:
0.000116
AC:
3
AN:
25792
East Asian (EAS)
AF:
0.0000254
AC:
1
AN:
39382
South Asian (SAS)
AF:
0.000235
AC:
20
AN:
85038
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52190
Middle Eastern (MID)
AF:
0.00384
AC:
22
AN:
5724
European-Non Finnish (NFE)
AF:
0.000321
AC:
355
AN:
1105126
Other (OTH)
AF:
0.00388
AC:
232
AN:
59826
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
95
190
285
380
475
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0123
AC:
1870
AN:
152142
Hom.:
40
Cov.:
33
AF XY:
0.0118
AC XY:
877
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.0407
AC:
1689
AN:
41524
American (AMR)
AF:
0.00830
AC:
127
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5134
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
67958
Other (OTH)
AF:
0.0133
AC:
28
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
87
173
260
346
433
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00553
Hom.:
2
Bravo
AF:
0.0141
Asia WGS
AF:
0.00231
AC:
8
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 16, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.73
DANN
Benign
0.66
PhyloP100
-0.087
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111592472; hg19: chr21-47537872; API